Oncology Institute, Inc.
Ticker: 1799191
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q1 FY2026 | Q3 FY2025 | Q2 FY2025 | Q1 FY2025 | Q3 FY2024 | Q2 FY2024 | Q1 FY2024 | Q3 FY2023 |
|---|---|---|---|---|---|---|---|---|
| INCOME | ||||||||
| Revenue | 147.44+8.0% | 136.56+14.0% | 119.80+14.7% | 104.41+4.5% | 99.90+1.3% | 98.58+4.1% | 94.67+15.4% | 82.04 |
| Total Income | 147.44+8.0% | 136.56+14.0% | 119.80+14.7% | 104.41+4.5% | 99.90+1.3% | 98.58+4.1% | 94.67+15.4% | 82.04 |
| EXPENSES | ||||||||
| Expenditure | 153.95+6.5% | 144.62+10.4% | 131.01+14.6% | 114.32+0.5% | 113.75-1.0% | 114.94+2.0% | 112.64+17.4% | 95.96 |
| Tax | 0.00 | 0.00+100.0% | -0.13 | 0.00 | 0.00 | 0.00 | 0.00-100.0% | 0.14 |
| PROFIT | ||||||||
| PBT | -2.49+84.9% | -16.50+3.7% | -17.14+12.5% | -19.59-21.6% | -16.11-4.1% | -15.48+22.2% | -19.89-15.1% | -17.28 |
| Net Profit | -2.49+84.9% | -16.50+3.0% | -17.01+13.2% | -19.59-21.6% | -16.11-4.1% | -15.48+22.2% | -19.89-14.2% | -17.42 |
| KEY METRICS | ||||||||
| OPM % | -4.42%+1.48pp | -5.90%+3.46pp | -9.36%+0.13pp | -9.49%+4.37pp | -13.87%+2.73pp | -16.60%+2.38pp | -18.98%-2.01pp | -16.97% |
| NPM % | -1.69%+10.40pp | -12.09%+2.11pp | -14.20%+4.56pp | -18.76%-2.63pp | -16.13%-0.43pp | -15.70%+5.31pp | -21.01%+0.22pp | -21.23% |
| EPS | -0.02+85.7% | -0.14+6.7% | -0.15+28.6% | -0.21-16.7% | -0.18-5.9% | -0.17+22.7% | -0.22-15.8% | -0.19 |
Corporate Events
Board MeetingTOI
202617Jun
Board Meeting
Annual Meeting of Stockholders to elect directors, ratify au…
SEC Filing ↗